Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
Authors:
- 1 August 2022
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 156 (2) , 284-290
Abstract
Background & objectives: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021). Methods: A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30th August to 16th September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district. Results: A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI: 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI: 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. Interpretation & conclusions: This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future.Keywords
This publication has 10 references indexed in Scilit:
- Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional studyPLOS Medicine, 2021
- The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological studyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2021
- Understanding COVID-19 vaccine hesitancyNature Medicine, 2021
- SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021International Journal of Infectious Diseases, 2021
- Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveysEpidemiology and Infection, 2021
- Strategy for COVID-19 vaccination in India: the country with the second highest population and number of casesnpj Vaccines, 2021
- SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurveyThe Lancet Global Health, 2021
- A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, IndiaIndian Journal of Medical Research, 2021
- Prevalence of SARS-CoV-2 infection in IndiaIndian Journal of Medical Research, 2020
- National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in IndiaIndian Journal of Medical Research, 2020